Pre-earnings options volume in AbSci Corp is normal with calls leading puts 8:3. Implied volatility suggests the market is anticipating a move near 16.5%, or 51c, after results ar ...

I think it's leveraging AI." Sean McClain, founder and CEO of Absci, and Christian Stegmann, SVP of Drug Creation, sit down with Andrew Galler to discuss Absci's generative AI platform and ...